Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries United Therapeutic (NQ: UTHR ) 338.22 +1.85 (+0.55%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about United Therapeutic < Previous 1 2 3 4 5 6 Next > The 3 Best 3D Bioprinting Stocks to Buy Now July 26, 2024 These are three of the best 3D bioprinting stocks to buy as the technology begins to hit its stride in the health care sector. Via InvestorPlace Navigating 9 Analyst Ratings For United Therapeutics July 25, 2024 Via Benzinga Beam Therapeutics Stock Earns RS Rating Jump To 85 July 24, 2024 On Wednesday, Beam Therapeutics stock now clears the 80 or higher Relative Strength Rating threshold, with a jump from 65 to 85. Via Investor's Business Daily Here's How Much $1000 Invested In United Therapeutics 5 Years Ago Would Be Worth Today July 22, 2024 Via Benzinga Biotech Arvinas Stock Earns 82 RS Rating July 17, 2024 The Relative Strength (RS) Rating for Arvinas stock entered a new percentile Wednesday, with a rise from 62 to 82. Via Investor's Business Daily Don't overlook NASDAQ:UTHR—it's a hidden gem with strong fundamentals and an attractive price tag. July 17, 2024 Despite its impressive fundamentals, UNITED THERAPEUTICS CORP (NASDAQ:UTHR) remains undervalued. Via Chartmill If You Invested $1000 In This Stock 20 Years Ago, You Would Have $28,000 Today July 16, 2024 Via Benzinga Unveiling 6 Analyst Insights On United Therapeutics July 08, 2024 Via Benzinga Deep Dive Into United Therapeutics Stock: Analyst Perspectives (5 Ratings) June 12, 2024 Via Benzinga Denali Therapeutics Stock Gets Technical Rating Upgrade July 16, 2024 Denali Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Via Investor's Business Daily 3 Biotech Stocks to Buy Now: Q3 Edition July 15, 2024 Biotech stocks to buy can be a strong portfolio addition due to their capability for rapid growth within an evolving industry. Via InvestorPlace 3 Undervalued Stocks on Track to Double (or More) by 2028 July 08, 2024 The stock market is on the brink of a multi-year bull market. Consider these undervalued growth stocks to buy that can double or more by 2028. Via InvestorPlace Members of Congress Buy and Sell Stocks. These ETFs Let You Invest Like Democrats or Republicans. July 02, 2024 Whether you'd like to invest like Nancy Pelosi or Ted Cruz, you can. But maybe you shouldn't. Via The Motley Fool Topics ETFs 7 Undervalued Biotech Stocks to Buy for Big-Time Returns July 01, 2024 The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive. Via InvestorPlace Expert Ratings For United Therapeutics May 21, 2024 Via Benzinga Chart Of The Day: United Therapeutics - Drugs For Chronic Illnesses June 28, 2024 United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening... Via Talk Markets UroGen Pharma Stock Earns 91 RS Rating June 27, 2024 UroGen Pharma stock had its Relative Strength (RS) Rating upgraded to 91 Thursday, up from 87 a day earlier. Via Investor's Business Daily When you look at NASDAQ:UTHR, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. June 26, 2024 UNITED THERAPEUTICS CORP (NASDAQ:UTHR) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. Via Chartmill Arcellx Stock Earns Relative Strength Rating Upgrade June 21, 2024 One key metric to look for in a stock is an 80-plus Relative Strength Rating. Arcellx stock cleared that benchmark Friday, jumping to 83. Via Investor's Business Daily The 3 Best Medical Device Stocks to Buy in June 2024 June 20, 2024 Medical devices are at the forefront of the digitalization of medicine. making these the three best medical device stocks to buy. Via InvestorPlace Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87 June 20, 2024 Intra-Cellular Therapies sees its Relative Strength Rating enter the 80-plus level. Via Investor's Business Daily 10 Health Care Stocks Whale Activity In Today's Session June 19, 2024 Via Benzinga Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans June 14, 2024 Neurocrine Biosciences has long been known for its blockbuster drug Ingrezza. It's diversifying, developing multiple drugs in related areas. Via Investor's Business Daily Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade June 12, 2024 On Wednesday, Madrigal Pharmaceuticals stock earned an upgrade to its Relative Strength (RS) Rating, from 74 to 90. Via Investor's Business Daily Krystal Biotech Stock Sees RS Rating Jump To 91 June 11, 2024 On Tuesday, Krystal Biotech stock cleared a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88. Via Investor's Business Daily 10 Health Care Stocks With Whale Alerts In Today's Session June 11, 2024 Via Benzinga Halozyme Therapeutics Scores RS Rating Jump To 91 June 07, 2024 On Friday, Halozyme Therapeutics stock earned an upgrade to its Relative Strength (RS) Rating, from 80 to 91. Via Investor's Business Daily For those who appreciate value investing, NASDAQ:UTHR is a compelling option with its solid fundamentals. June 05, 2024 Investors should take notice ofUNITED THERAPEUTICS CORP (NASDAQ:UTHR)—it offers a great deal for the fundamentals it presents. Via Chartmill The 3 Most Undervalued Healthcare Stocks to Buy in June 2024 June 04, 2024 Seeking discounts in relevant places makes sense and there are few arenas more compelling than undervalued healthcare stocks. Via InvestorPlace Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics June 03, 2024 Liquidia stock retook its 50-day line Monday on a U.S. judge's ruling on a patent dispute with fellow biotech company United Therapeutics. Via Investor's Business Daily Topics Intellectual Property Exposures Intellectual Property < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.